E.cuniculi is a widespread protozoan parasite of rabbits responsible for serious illness in rabbits including neurologic disease, eye problems and kidney failure. Panacur Rabbit is indicated as an aid in the control of this parasite.
Syringes containing 5 g of an 18.75 % oral paste formulation.
1 g contains 0.187 g active ingredient fenbendazole.
Indications for use
Panacur rabbit is a broad spectrum anthelmintic given orally as an aid in the control and treatment of Encephalitozoon cuniculi (E. cuniculi) and intestinal worms in domestic rabbits.
Panacur Rabbit can be used as part of a preventative healthcare plan (1 syringe graduation per 2.5 kg bodyweight (20 mg/kg fenbendazole)) daily for 9 consecutive days.
Dosing should also be considered during periods of higher risk, such as when the rabbit is acquired, prior to mating and when mixing with other rabbits.
For rabbits with clinical signs associated with E. cuniculi a treatment course of 20 mg/kg (1 syringe graduation per 2.5 kg bodyweight) daily for 28 days is recommended.
5 g syringes and packs of 10 x 5 g syringes.
This veterinary medicine is marketed in accordance with the Small Animal Exemption Scheme.
For full information please refer to the product data sheet. Further information is available on request.
Use Medicines Responsibly. For more information please refer to the Responsible Use sections of the NOAH website.
Date of preparation: January 2018